Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H21N3O2.C7H6O3 |
Molecular Weight | 413.4669 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=C(O)C=CC=C1.[H][C@]23N(C)CC[C@@]2(C)C4=C(C=CC(OC(=O)NC)=C4)N3C
InChI
InChIKey=HZOTZTANVBDFOF-PBCQUBLHSA-N
InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1
Molecular Formula | C15H21N3O2 |
Molecular Weight | 275.3461 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C7H6O3 |
Molecular Weight | 138.1207 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:57 UTC 2023
by
admin
on
Fri Dec 15 15:16:57 UTC 2023
|
Record UNII |
2046ZRO9VU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47792
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
||
|
FDA ORPHAN DRUG |
183
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
27953
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
DBSALT001541
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
1537003
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
CHEMBL94
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
2046ZRO9VU
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
57-64-7
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
757275
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
C026718
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
200-343-8
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
33656
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID80883232
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
m8766
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000079464
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
C81336
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
2046ZRO9VU
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
PHYSOSTIGMINE SALICYLATE
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | Description: Colourless crystals; odourless. Solubility: Sparingly soluble in water; soluble in ethanol (~750 g/l) TS; slightly soluble in ether R. Category: Anticholinesterase; miotic. Storage: Physostigmine salicylate should be kept in a tightly closed container, protected from light, and preferably in quantitiesnot exceeding 1 g. Additional information: Physostigmine salicylate is very poisonous. It acquires a red tint when exposed to air or light. All testsshould be performed on freshly prepared solutions. Definition: Physostigmine salicylate contains not less than 98.0% and not more than 101.0% of C15H21N3O2,C7H6O3, calculatedwith reference to the dried substance. | ||
|
5992
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
SUB14865MIG
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY | |||
|
48883
Created by
admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |